Homology Medicines Inc.

NASDAQ: FIXX · Real-Time Price · USD
0.93
0.00 (0.26%)
At close: Mar 25, 2024, 9:00 PM

Homology Medicines Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-47.73M -112.96M -5M -95.76M
Depreciation & Amortization
-27K 578K 1.29M 8.35M
Stock-Based Compensation
4.39M 7.32M 13.05M 17.25M
Other Working Capital
n/a -9.3M 4.33M -39.32M
Other Non-Cash Items
n/a 18.13M -126.35M 1.19M
Deferred Income Tax
n/a n/a n/a 1.03M
Change in Working Capital
n/a -7.21M 3.35M -41.8M
Operating Cash Flow
-67.72M -96.23M -113.66M -109.75M
Capital Expenditures
-75K -228K -1.28M -2.4M
Cash Acquisitions
n/a n/a 130M 48.39M
Purchase of Investments
n/a -73.24M -157.46M -97.39M
Sales Maturities Of Investments
20M 174.24M 65.46M 49M
Other Investing Acitivies
n/a n/a 38M -48.39M
Investing Cash Flow
19.93M 101.33M 36.72M -50.79M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
53.14M 184K 596K 52.17M
Financial Cash Flow
95.14M 184K 596K 52.17M
Net Cash Flow
47.35M 5.28M -76.35M -108.37M
Free Cash Flow
-67.79M -96.46M -114.95M -112.15M